You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas
Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level
Login
Username:

Password:


Related Headlines

Insilico initiates Rentosertib Phase III clinical trial for idiopathic pulmonary fibrosis

Aptamer Group launches Optimer-based Ebola diagnostic programme

Physiomics secures new contracts worth over GBP200,000

Wiley announces launch of Advanced Immunology open access journal

EDX Medical to provide molecular profiling services to Astron Health

EQT to acquire biosurgery company Corza Biosurgery

IceCure reports growing adoption of ProSense cryoablation in Brazil

PharmaEssentia secures Health Canada approval for BESREMi in polycythaemia vera

Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level

Insulet expands European footprint with Omnipod 5 and Omnipod Discover launch in Spain

Signatera study links MRD status to survival benefit from chemotherapy in colorectal liver metastases

Northwest Biotherapeutics presents on propensity score matching at BNOS 2026

Taiwan biomedical startups hold over 100 business meetings at BIO 2026

Sanyou Bio and Baiyunshan Xihe partner to develop radiopharmaceuticals and radiodiagnostics

Novartis to acquire Myricx Bio in deal worth up to USD1.5bn

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026